---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-006460"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:08:35.565838+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# IRADIMED reports record Q1 revenue of $17.6M, up 13.7% YoY; EPS $0.32 GAAP, $0.36 non-GAAP

## Summary
- Q1 2024 record revenue $17.6M, +13.7% YoY; operating income $4.7M, +18.5%.
- GAAP diluted EPS $0.32, non-GAAP $0.36; net income $4.1M, +21.4%.
- Declared regular quarterly dividend of $0.15/share payable May 30, 2024 to holders of record May 20.
- Q2 2024 guidance: revenue $17.6-17.8M, GAAP EPS $0.33-0.36, non-GAAP $0.36-0.39.
- FY 2024 guidance reiterated: revenue $72-74M, GAAP EPS $1.37-1.47, non-GAAP $1.52-1.62.

## SEC filing metadata
- accession: 0001558370-24-006460
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837024006460/0001558370-24-006460-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837024006460/irmd-20240502x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-006460
- JSON: https://secwatch.observer/filing/0001558370-24-006460.json
- Plain text: https://secwatch.observer/filing/0001558370-24-006460.txt

## Key facts
- Earnings Releases
  IRADIMED CORP reported the three months ended March 31, 2024 results: revenue $17.6 million, net income $4.1 million, EPS $0.32 per diluted share. Guidance reaffirmed.
  - Period: the three months ended March 31, 2024
  - Revenue: $17.6 million
  - Net income: $4.1 million
  - EPS: $0.32 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share ● Reports record revenue of $17.6 million for the first quarter of 2024. ​ ● Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024. ​ ● Reports first quarter of 2024 operating
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837024006460/0001558370-24-006460-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.